warning
3 events
A92-A99 • EUR
Lassa fever in United Kingdom of Great Britain and Northern Ireland
Lassa fever has 3 WHO-tracked outbreak events in United Kingdom of Great Britain and Northern Ireland between 2000 and 2022.
Lassa fever · United Kingdom of Great Britain and Northern Ireland · 3 WHO events across 3 calendar years (2000–2022).
Event log
| Year | DON ID | ICD-10 | ICD-11 |
|---|---|---|---|
| 2022 | DON2717 | A962 |
1D61 |
| 2003 | DON0659 | A962 |
1D61 |
| 2000 | DON0379, DON0380 | A962 |
1D61 |
Annual cadence
| Year | Events |
|---|---|
| 2022 | 1 |
| 2003 | 1 |
| 2000 | 1 |
Most active year: 2022 with 1 event.
Quiet years with no events: 20.
Position within the disease
- United Kingdom of Great Britain and Northern Ireland is rank #2 of 13 for this disease.
- The country sits in the WHO EUR region.
- Last reported event: 2022 (4 years ago).
Regional peers (EUR)
4 countries in this region report this disease. Median event count: 3.
| Country | Events |
|---|---|
| United Kingdom of Great Britain and Northern Ireland ← | 3 |
| Germany | 3 |
| Netherlands | 2 |
| Sweden | 1 |
How this disease ranks among United Kingdom of Great Britain and Northern Ireland’s threats
Lassa fever is rank #4 of 19 diseases reported by United Kingdom of Great Britain and Northern Ireland to the WHO. The full country profile is at the United Kingdom of Great Britain and Northern Ireland Hub.
United Kingdom of Great Britain and Northern Ireland health system snapshot
| Indicator | 2023 |
|---|---|
| Population | 67,000,000 |
| Life expectancy | 81.20 yr |
| Healthy life expectancy | 70.10 yr |
| Hospital beds /1k | 2.50 |
| Physicians /1k | 3.00 |
| Healthcare spending % GDP | 11.90% |
| DTP3 vaccination | 95.00% |
| TB incidence /100k | 8.00 |
| HIV prevalence | 0.20% |
Outbreak Events
3
First Reported
2000
Latest Reported
2022
Country
United Kingdom of Great Britain and Northern Ireland • EUR